Retinal degenerative and neovascular diseases, including age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma and rare monogenic dystrophies are major causes for global severe vision loss or blindness. In recent years, neuroinflammatory mechanisms have been identified as major factors for triggering the onset and progression of all these retinal diseases. Loss of retinal immune homeostasis is often accompanied by profound changes in cellular and humoral innate immunity and also involves adaptive immune responses by invading blood cell populations. We are only just beginning to understand the complex ocular inflammatory mechanisms and interplay between immune cells that occur in the eyes of patients with visual impairment.
This Collection seeks to discover novel immune mechanisms in the diseased retina that may offer novel diagnostic markers or highlight targets for immuno-modulatory therapies that could help to reduce the burden of vision loss worldwide.
As part of this Collection, we invite articles that cover the following topics:
• Role of resident and invading mononuclear phagocytes in the retina
• Role of T-cells and B-cells in retinal disease
• Complement factors in retinal disease
• Retinal pigment epithelium (RPE) inflammasome
• Immune responses in retinal gene therapy
• Microbiome and retinal immunity
• Retinal Immune memory and epigenetics
• Cellular senescence and retinal immune system
• Microglia-glia interactions in the retina